Adeptia Named a Value Leader in EMA Radar for Integration Technologies for Hybrid Cloud: Q4 2012
Adeptia Inc., a leading provider of innovative cloud and on-premise business process integration solutions, today announced it has been named a “Value Leader” in the 2012 Enterprise Management Associates (EMA) Radar™ for Integration Technologies for Hybrid Cloud: Q4 2012 report, for Adeptia’s Enterprise Business Integration Management Suite (EBIMS). Adeptia was also honored with the EMA Recognition Award for “Best Integration Workflow Functionality.”The EMA Radar Report, produced by leading industry analyst firm Enterprise Management Associations, provides an in-depth analysis of industry-leading vendors and vendor products including their overall market position in comparison to other vendors. As EMA notes, “today’s companies are increasingly “integrating the Cloud.” SaaS to SaaS, on-premise to SaaS, and multi-platform integrations are commonplace. This radar examines the technologies companies are using to accomplish integrations, as well as the scenarios, roles, and processes that are driving this evolution.”
Adeptia: Value Leader
Adeptia’s Enterprise Business Integration Management Suite was recognized by EMA as a Value Leader based on the high scoring in product strength and cost efficiency categories.
Adeptia: Best Integration Workflow Functionality
Some of the winning attributes noted by EMA for their selection of Adeptia for this category include:
Overall: “Adeptia’s ability to combine rich integration capabilities with a full-fledged workflow engine that supports combinations of human workflow and long running transactions, maintaining transaction state throughout. […] EBIM takes the state-of-the-art meta-driven approach to creation and deployment of process flows. The process flow that is deployed is an XML file and at run-time the execution occurs based on activity rules that are read by the process engine from the services repository.”
Functionality: “The fact that [Adeptia] was designed for use by business users is evident in the product and was mentioned as a differentiator in customer interviews. This ease of use is enabled by an intuitive and essentially “point and click” GUI. Adeptia has also incorporated high levels of manageability into its product, with reporting on time spent at each tier, error log entries, and hung transactions, for example.”
Deployment and Administration: Adeptia scored well in this area, based on fast deployment, a variety of on-premise and public Cloud-based form factors, and broad database options. They also offer a wide range of support options, and customers indicate that the customer support experience is exceptional. One of the few integration solutions that can realistically be administered by a non-expert.
Differentiators include: state-based processing supporting long running transactions, clustering and fault tolerance, process recovery and rollback.
“Adeptia’s unique platform can help companies stand-out in the marketplace, and deliver value to both internal and external clients,” said Deepak Singh, Adeptia President and CTO. “We have simplified the integration process, delivering a seamless, cost-effective experience for both IT and business stakeholders. Also eliminating, in many cases, the need for hiring outside professional services vendors.”
About the EMA Radar Report:
The EMA Radar Report (produced by Enterprise Management Associates, a leading industry analyst firm) delivers an in-depth analysis of industry-leading vendors and vendor products, including their overall market position in comparison with other vendors. This information is laid out in an easy-to-decipher, detailed Radar Chart, making it simple to see how vendors measure up in the market, as well as against other vendors. The EMA Radar report also provides a detailed discussion of methodology and criteria, a high-level market segment overview, and a comprehensive analyst write-up on each vendor.
Adeptia is the leading provider of innovative SOA cloud and on-premise business process integration and middleware solutions. Adeptia's unique offering combines data integration, application integration, B2B integration, and Business Process Management into a single application. Over 380 customers, ranging from Fortune 1000 companies to mid-sized and small businesses have deployed Adeptia's reusable and highly scalable technology.
Learn more by visiting www.adeptia.com.
For media inquiries contact:
Adeptia Inc
Andrew Griffin, (815) 298-8551
andy.griffin@adeptia.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Adeptia Named a Value Leader in EMA Radar for Integration Technologies for Hybrid Cloud: Q4 2012 here
News-ID: 253267 • Views: …
More Releases from Adeptia Inc
Adeptia Announces 75% Revenue Increase for 2012 Calendar Year
Adeptia, a leading provider of innovative cloud and on-premise business process integration solutions, today announced a 75 percent revenue growth in 2012 contributing to record profitability for the third consecutive year. The increased revenue is a result of new customer deals, expansion within the existing customer base, and new OEM partnerships.
Adeptia was also recently recognized by Enterprise Management Associates as a “Value Leader” in the 2012 Enterprise Management Associates (EMA)…
More Releases for EMA
Ethylene Methacrylic Acid (EMA) Market Size, Share, Development by 2025
LP INFORMATION recently released a research report on the Ethylene Methacrylic Acid (EMA) market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Ethylene Methacrylic Acid (EMA)market by key players, product type, applications and regions,etc.
The main objective of this market research is to help the readers understand the structure of Ethylene Methacrylic Acid (EMA)market, market definition,…
ECA Foundation added to EMA List of Stakeholder Organisations
The ECA Foundation is now listed in the European Medicines Agency's (EMA) list of eligible industry stakeholder organisations (www.ema.europa.eu/en/documents/other/list-eligible-industry-stakeholder-organisations_en.pdf). Pre-requisite for this entry is the listing in the EU's Transparency Register (http://ec.europa.eu/transparencyregister/public/consultation/searchControllerPager.do?declaration=ECA%20Foundation&search=search&locale=en#en) - where the ECA has been registered since January 2019.
The ECA Foundation is the leading European organisation with regard to pharmaceutical Quality Assurance and GMP compliance.
The ECA Foundation is a not for profit organisation. The ECA is headed…
EMA at IoThings 2019, Milan
The 2019 Spring edition of IoThings in Milan hosted a multitude of companies. Numerous participants from all over Europe engaged in conferences, business meetings and expos like ITALI5G, AI + BOTS World and Blockchain Now to offer a unique advantage through the most disruptive technologies of today.
Staged at Booth#38, EMA sported a gamified implementation of IoT for our audience to interact with. Our demonstration aimed to display our engineering prowess…
Hardening Machines Market: EMA Indutec, SMS Elotherm GmbH, EMAG Machine Tools
MarketResearchReports.Biz has recently announced the Latest industry research report on: "Global Hardening Machines Market" : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts.
This report studies the global Hardening Machines market status and forecast, categorizes the global Hardening Machines market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India…
EMA grants orphans drug status to Therabron Therapeutics’ CG367
March 1, 2017 Orphan Drug
European Medicine Agency has awarded Therabron Therapeutics, a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care; with Orphan drug Designation for its leading product candidate, CG367, for the treatment of patients with Bronchiolitis Obliterans Syndrome (BOS).
BOS is extremely serious and life threatening combination of lung transplantation, which generally manifests between 18 months to four years after the procedure. Additionally, the…
EMA Calls Evolven Most Adaptive Change Management Analytics
Evolven (http://www.evolven.com) today announced that the company’s change and configuration monitoring solution was recognized in a new Enterprise Management Associates (EMA) report, calling the application the industry’s most adaptive change management analytics.
In this report, EMA senior analysts, Dennis Drogseth(Vice President) and Charlie Betz (Research Director) explore why it has never been more challenging to effectively cope with the impact of change and configuration issues, and how IT operation…